Driehaus Capital Management LLC Karuna Therapeutics, Inc. Transaction History

Driehaus Capital Management LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	BUY	$161.01 - $317.85 $925,002 - $1.83 Million	5,745 Added 6.34%	96,424 $30.5 Million
Q3 2023 Nov 14, 2023	BUY	$164.66 - $218.08 $37,707 - $49,940	229 Added 0.25%	90,679 $15.3 Million
Q2 2023 Aug 14, 2023	BUY	$176.32 - $240.22 $533,896 - $727,386	3,028 Added 3.46%	90,450 $19.6 Million
Q1 2023 May 15, 2023	BUY	$161.33 - $204.36 $334,275 - $423,433	2,072 Added 2.43%	87,422 $15.9 Million
Q4 2022 Feb 14, 2023	BUY	$191.53 - $236.82 $361,034 - $446,405	1,885 Added 2.26%	85,350 $16.8 Million
Q3 2022 Nov 14, 2022	BUY	$123.79 - $277.42 $10.3 Million - $23.2 Million	83,465 New	83,465 $18.8 Million

332K

Ticker KRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 33,965,000
Description
Karuna Therapeutics, Inc., a clinical-stage biopharmaceutical company, creates and delivers transformative medicines for people living with psychiatric and neurological conditions. Its lead product candidate is KarXT, an oral modulator of muscarinic receptors that is in Phase III clinical trial for the treatment of acute psychosis in patients wi...

Get notified when there are updates to the investment portfolio of Driehaus Capital Management LLC, based on Form 13F filings with the SEC.

Stay updated on Driehaus Capital Management LLC with notifications on news.